These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 3927648)

  • 21. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
    Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
    Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
    Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion.
    Serri O
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ovine corticotrophin-releasing factor and hydrocortisone on growth hormone secretion by pituitary adenoma cells of acromegaly in culture.
    Ishibashi M; Hara T; Tagusagawa Y; Fukushima T; Numata H; Hori T; Yamaji T
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):443-7. PubMed ID: 6332444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
    Nakagawa K; Akikawa K; Matsubara M; Kubo M
    J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients.
    Shibasaki T; Shizume K; Masuda A; Nakahara M; Hizuka N; Miyakawa M; Takano K; Demura H; Wakabayashi I; Ling N
    J Clin Endocrinol Metab; 1984 Jan; 58(1):215-7. PubMed ID: 6417156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium.
    Lipson LG; Beitins IZ; Kornblith PL; McArthur JW; Friesen HG; Kliman B; Kjellberg RN
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):421-33. PubMed ID: 218413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone-releasing factor regulates growth hormone mRNA in primary cultures of rat pituitary cells.
    Gick GG; Zeytin FN; Brazeau P; Ling NC; Esch FS; Bancroft C
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1553-5. PubMed ID: 6424119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phorbol ester, not growth hormone releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture.
    Emoto N; Ohmura E; Isozaki O; Tsushima T; Shizume K; Demura H
    Clin Endocrinol (Oxf); 1991 May; 34(5):377-82. PubMed ID: 2060147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory role of galanin in control of hypothalamic-anterior pituitary function.
    Ottlecz A; Snyder GD; McCann SM
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9861-5. PubMed ID: 2462256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.
    Penny ES; Penman E; Price J; Rees LH; Sopwith AM; Wass JA; Lytras N; Besser GM
    Br Med J (Clin Res Ed); 1984 Aug; 289(6443):453-5. PubMed ID: 6432140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
    Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
    Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation.
    Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
    Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.